TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), has been named a 2025 Life Sciences Award winner by Triangle Business Journal in recognition of its scientific expertise, operational excellence, and growing impact within North Carolina’s dynamic life sciences ecosystem. With a specialized focus in dermatology, internal medicine, neuroscience, oncology, and ophthalmology, TFS has distinguished itself as a global CRO delivering deep therapeutic knowledge, strategic partnerships, and meaningful contributions to both local and international clinical research communities.  

“The Triangle is one of the preeminent places for the life sciences sector,” said Sougata Mukherjee, President and Publisher of Triangle Business Journal. “These honorees represent the substantial impact this area has on this industry, and I’m excited to celebrate their successes.” 

TFS strengthened its global presence in 2024 with strategic expansion into Asia-Pacific and new partnerships—including collaborations with RetinAI and MAXO to accelerate ophthalmology research and integrate AI-driven insights into trial design. Locally, the company deepened its commitment to the Triangle by expanding its leadership footprint and investing in regional talent, reinforcing Raleigh-Durham’s growing reputation as a global hub for clinical development.  

“Being recognized by the Triangle Business Journal is an honor for our organization,” said Markus Granlund, CEO of TFS. “The Triangle is not only a global hub for innovation—it’s home to a growing part of our leadership, our partnerships, and our purpose. This recognition reflects our deepening commitment to this vibrant community and our ongoing mission to empower scientific progress that enriches lives worldwide.” 

TFS also distinguished itself through its commitment to sustainability and community engagement. The company earned its fifth consecutive EcoVadis Silver Rating, placing it among the top 15% of companies globally for sustainability, and improved its Carbon Disclosure Project (CDP) score in 2024. TFS also supported leading nonprofits focused on cancer research, ophthalmology, and rare diseases while employees actively participated in local events such as the St. Jude Triangle Run/Walk. 

As the Triangle continues to rise as a life sciences powerhouse, TFS remains committed to advancing the sector through meaningful scientific partnerships, sustainable clinical practices, and a people-first culture rooted in its mission: Empowering partners and enriching lives.